How to Get Crestor (Rosuvastatin) in Utah

At a glance
- Generic name / rosuvastatin calcium, brand Crestor (AstraZeneca)
- Dose forms / 5 mg, 10 mg, 20 mg, 40 mg oral tablets, taken once daily
- Utah telehealth prescribing / fully legal for rosuvastatin
- Utah Medicaid coverage / brand Crestor is not covered; generic rosuvastatin may require prior authorization
- 503A compounding in Utah / permitted through state-licensed 503A pharmacies
- Retail pharmacy availability / stocked at Intermountain Health pharmacies, Walgreens, CVS, Smith's, Costco, and independents statewide
- Prescribers allowed / MDs, DOs, NPs (with prescriptive authority), and PAs under physician collaboration
- Average generic cost / $8 to $25 for a 30-day supply without insurance
- Key pre-prescription labs / fasting lipid panel, ALT, AST, and eGFR/creatinine
Why Rosuvastatin Is a First-Choice Statin
Rosuvastatin is the most potent HMG-CoA reductase inhibitor on the U.S. market, producing LDL-C reductions of 46% to 55% across the 10 mg to 40 mg dose range according to the FDA-approved prescribing information. That LDL-lowering capacity made it the drug tested in JUPITER, the landmark primary-prevention trial published in the New England Journal of Medicine. JUPITER (N=17,802) randomized adults with LDL-C <130 mg/dL but elevated high-sensitivity C-reactive protein to rosuvastatin 20 mg or placebo. The rosuvastatin group experienced a 44% relative reduction in the primary cardiovascular endpoint (HR 0.56, 95% CI 0.46 to 0.69, P<0.00001) over a median follow-up of 1.9 years [1].
That data reshaped the 2018 ACC/AHA cholesterol guidelines, which now position high-intensity rosuvastatin (20 to 40 mg) as a recommended option for patients with clinical ASCVD or LDL-C ≥190 mg/dL [2]. For Utah residents carrying cardiovascular risk factors, access to this medication is straightforward once a prescriber confirms clinical appropriateness and reviews baseline labs.
Getting a Rosuvastatin Prescription in Utah
Utah law permits any licensed physician (MD or DO), nurse practitioner with full prescriptive authority, or physician assistant working under a collaborative agreement to prescribe rosuvastatin. The process is standard: a clinician reviews your lipid panel, cardiovascular risk profile, and relevant medical history before writing the prescription.
NPs in Utah gained full practice authority in 2016. They can independently evaluate, diagnose, and prescribe schedule II, V and non-controlled medications without a physician co-signature. PAs still operate under a collaborative practice agreement with a supervising physician, but they prescribe rosuvastatin routinely in both primary care and cardiology settings across the Wasatch Front and rural Utah clinics.
If you already take rosuvastatin and are moving to or visiting Utah, any Utah-licensed prescriber can write a new prescription based on your existing records. Bring your most recent lipid panel, your current dose, and a list of other medications. Pharmacies can also process prescription transfers from out-of-state pharmacies under Utah Administrative Code R156-17b, which governs interstate prescription reciprocity through the pharmacy practice act [3].
Telehealth Access to Rosuvastatin in Utah
Telehealth is a fully legal prescribing pathway for rosuvastatin in Utah. A synchronous video or audio visit with a Utah-licensed clinician satisfies the state's prescriber-patient relationship requirements for non-controlled medications.
Several telehealth platforms operate in Utah, including HealthRX, which connects patients with board-certified providers who can evaluate cardiovascular risk, order labs, and e-prescribe rosuvastatin to a local or mail-order pharmacy. The typical workflow takes three steps: complete an intake questionnaire, attend a synchronous provider visit (often 10 to 20 minutes), and receive an electronic prescription sent directly to your preferred pharmacy.
Telehealth is particularly relevant for patients in rural Utah counties (Daggett, Piute, Wayne, Garfield) where the nearest primary care office may be 60 miles or more away. The 2023 HRSA Area Health Resources Files report that 15 of Utah's 29 counties qualify as medically underserved areas, making virtual statin prescribing a practical tool for closing gaps in preventive cardiovascular care [4].
One clinical nuance: your telehealth provider will still need fasting labs before initiating or adjusting rosuvastatin. Most telehealth services partner with national lab networks (Quest Diagnostics, Labcorp) or accept results from local facilities like ARUP Laboratories headquartered in Salt Lake City.
Labs Required Before Starting Rosuvastatin
Before any prescriber in Utah writes a rosuvastatin prescription, they will order a fasting lipid panel (total cholesterol, LDL-C, HDL-C, triglycerides) and a hepatic function panel (ALT and AST at minimum). These are standard requirements from the FDA label, which states that liver enzymes should be checked before initiation and "when clinically indicated thereafter" [5].
A baseline renal function test (serum creatinine or eGFR) is also recommended. Rosuvastatin undergoes minimal hepatic metabolism through CYP2C9 and is primarily excreted unchanged in feces, but the 40 mg dose is contraindicated in patients with eGFR <30 mL/min/1.73 m² due to increased systemic exposure [5]. A 10-year ASCVD risk calculation using the Pooled Cohort Equations rounds out the clinical picture and determines whether moderate-intensity (5 to 10 mg) or high-intensity (20 to 40 mg) dosing is appropriate per ACC/AHA guidelines [2].
Most Utah labs return lipid panel and hepatic function results within 24 to 48 hours. After your prescriber reviews the numbers, the prescription can be electronically transmitted the same day.
Follow-up labs are typically drawn at 4 to 12 weeks after starting therapy to confirm LDL-C response and check for transaminase elevations. If LDL-C has not dropped by at least 30% on a moderate-intensity dose or 50% on a high-intensity dose, your provider will reassess adherence, drug interactions, and potential dose adjustment.
Where to Fill Rosuvastatin in Utah
Generic rosuvastatin is stocked at virtually every retail pharmacy in Utah. Here are the main categories of fill options.
Retail chains. Walgreens, CVS, Rite Aid, Smith's (Kroger), Harmons, and Costco all carry generic rosuvastatin. The cash price for a 30-day supply of rosuvastatin 20 mg typically ranges from $8 at Costco (no membership required for pharmacy) to $22 at chain pharmacies without a discount card. GoodRx and RxSaver coupons often bring the price to $10 to $15 at participating locations.
Intermountain Health pharmacies. Intermountain operates outpatient pharmacies across its hospital and clinic network in Utah. Patients in the Intermountain system can fill prescriptions at locations in Salt Lake City, Murray, Provo, Ogden, St. George, and Cedar City, among others.
Mail-order and 90-day supply. Insurance plans with mail-order benefits (Express Scripts, Optum Rx, Caremark) often provide a 90-day supply for the cost of two copays. For cash-pay patients, Mark Cuban's Cost Plus Drugs prices generic rosuvastatin 20 mg at $4.20 for a 30-day supply plus a flat dispensing and shipping fee.
503A compounding pharmacies. Utah licenses 503A compounding pharmacies through the Division of Occupational and Professional Licensing (DOPL). While rosuvastatin is commercially available and rarely compounded, a 503A pharmacy could prepare a custom formulation (suspension for patients who cannot swallow tablets) with a patient-specific prescription. These pharmacies can ship within Utah's borders.
Utah Medicaid, Insurance, and Prior Authorization
Brand-name Crestor is not covered by Utah Medicaid's preferred drug list for hyperlipidemia and ASCVD prevention. However, generic rosuvastatin is available through most Utah Medicaid managed care plans (Molina Healthcare of Utah, SelectHealth Community Care, Healthy U) with step therapy or prior authorization requirements that vary by plan.
The Endocrine Society's 2020 clinical practice guideline recommends high-intensity statin therapy for patients with LDL-C ≥190 mg/dL and for those with diabetes aged 40 to 75, which aligns with criteria most Utah insurers use when approving rosuvastatin without a generic atorvastatin trial first [6].
Prior authorization for rosuvastatin (when required) typically demands the following documentation:
- Diagnosis code for hyperlipidemia (E78.0, E78.5) or ASCVD (I25.10)
- Documented trial of or clinical rationale for not using atorvastatin
- Recent fasting lipid panel with LDL-C values
- 10-year ASCVD risk score for primary prevention patients
- Provider's clinical justification for rosuvastatin specifically (e.g., superior LDL-C lowering, CYP3A4 interaction concern with atorvastatin)
Processing time ranges from 24 hours (electronic PA) to 5 to 7 business days (fax-based). If denied, Utah insurers must provide a written explanation and offer an appeal process under Utah Insurance Code §31A-22-618.
For commercially insured patients, generic rosuvastatin sits on tier 1 or tier 2 of most formularies with copays between $0 and $15. Brand Crestor landed on tier 3 or non-preferred brand status at most Utah plans after patent expiration in 2016. The AAFP recommends prescribers default to generic rosuvastatin for cost-effectiveness unless a specific clinical reason necessitates the brand [7].
Rosuvastatin Dosing and Safety for Utah Patients
Standard dosing follows the FDA label: 5 mg to 40 mg once daily, taken with or without food. The 2018 ACC/AHA guideline defines high-intensity as rosuvastatin 20 to 40 mg (expected LDL-C reduction ≥50%) and moderate-intensity as rosuvastatin 5 to 10 mg (expected reduction of 30 to 49%) [2].
Dr. Donald Lloyd-Jones, chair of the 2019 ACC/AHA primary prevention guideline writing committee, stated: "The decision to start a statin should always begin with a clinician-patient risk discussion. The 10-year risk estimate is a starting point, not a mandate" [8]. That guidance applies equally whether you sit in a Salt Lake City cardiology office or a telehealth visit from Moab.
A second expert perspective comes from the Endocrine Society: "In patients at very high cardiovascular risk who do not achieve an adequate response with maximally tolerated statin therapy, the addition of ezetimibe or a PCSK9 inhibitor should be considered" [6].
The most commonly reported adverse effects of rosuvastatin are myalgia (reported in 2% to 11% of trial participants across post-marketing studies), headache, nausea, and abdominal pain. The JUPITER trial found that the incidence of myopathy (CK >10× ULN with muscle symptoms) was 0.1% in both the rosuvastatin and placebo groups, confirming a low absolute risk of serious muscle injury [1].
Patients of Asian descent should be started at 5 mg because pharmacokinetic studies show approximately 2-fold higher rosuvastatin exposure in this population [5]. Utah's Asian American community (approximately 4.3% of the state population per 2024 Census estimates) should be counseled on this dosing consideration.
Drug interactions to flag: rosuvastatin exposure increases with concomitant cyclosporine (contraindicated), gemfibrozil (use with caution), and certain HIV protease inhibitors. Unlike atorvastatin and simvastatin, rosuvastatin has minimal CYP3A4 involvement, which means grapefruit juice and many CYP3A4 inhibitors do not meaningfully alter its levels. This pharmacokinetic advantage is one reason prescribers choose rosuvastatin over atorvastatin in patients with complex medication regimens.
Timeline from Consultation to First Dose in Utah
How long does the entire process take? For most Utah residents, the answer is 2 to 5 days. Here is a realistic timeline:
Day 1. Schedule a telehealth or in-person visit. Complete intake forms and provide medical history. If labs are needed, get a requisition the same day.
Day 2. Draw fasting blood at a local lab (ARUP, Quest, Labcorp, or Intermountain lab). Results typically return within 24 hours for a standard lipid panel.
Day 3. Your provider reviews results, confirms rosuvastatin is appropriate, and e-prescribes to your pharmacy.
Day 3 to 4. Pick up your prescription at a retail pharmacy (often ready within 2 to 4 hours of receipt) or await mail-order shipment (1 to 3 business days via USPS Priority).
If you already have recent labs (drawn within the past 3 months and showing relevant lipid and liver values), a telehealth provider may prescribe on the same day as your initial visit, compressing the timeline to 24 hours from consult to pharmacy pickup.
Prior authorization, if required by your insurer, adds 1 to 7 business days depending on the payer's electronic PA capabilities.
Frequently asked questions
›How do I get a Crestor prescription in Utah?
›What labs are needed before Crestor in Utah?
›Are there telehealth providers in Utah prescribing Crestor?
›How long until I receive Crestor in Utah?
›Can I transfer a Crestor prescription to Utah?
›Are 503A pharmacies in Utah licensed to ship rosuvastatin?
›Who can prescribe Crestor in Utah: MD vs NP vs PA?
›What documentation does prior authorization require in Utah?
›Is brand Crestor covered by Utah Medicaid?
›How much does generic rosuvastatin cost in Utah without insurance?
›Do I need to fast before labs for a rosuvastatin prescription?
›Can I get rosuvastatin 40 mg prescribed via telehealth in Utah?
References
- Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195-2207. PubMed
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. Circulation. 2019;139(25):e1082-e1143. AHA Journals
- Utah Division of Occupational and Professional Licensing. Pharmacy Practice Act, Utah Administrative Code R156-17b. NCBI Bookshelf
- Health Resources and Services Administration. Area Health Resources Files, 2023. NIH
- U.S. Food and Drug Administration. Crestor (rosuvastatin calcium) prescribing information. Revised 2023. FDA
- Buse JB, Wexler DJ, Tsapas A, et al. 2019 update to: management of hyperglycemia in type 2 diabetes. J Clin Endocrinol Metab. 2020;105(12):e4356. Oxford Academic
- American Academy of Family Physicians. Statins for primary prevention of cardiovascular disease. Am Fam Physician. 2023. AAFP
- Arnett DK, Blumenthal RS, Michos ED, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Circulation. 2019;140(11):e596-e646. AHA Journals